المؤلفون: Toshiki Iwai, Masamichi Sugimoto, Namrata S. Patil, Daniel Bower, Miho Suzuki, Chie Kato, Keigo Yorozu, Mitsue Kurasawa, David S. Shames, Osamu Kondoh

المصدر: Scientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-2322

URL الوصول: https://doaj.org/article/4b94adbd323b4bf69ee418f876c26582

المؤلفون: Marcin Kowanetz, Thomas Powles, Hartmut Koeppen, Jane Grogan, Patrick Caplazi, Ira Mellman, Wei Zou, Sanjeev Mariathasan, Priti S. Hegde, Mark McCleland, Jacqueline McBride, Zora Modrusan, Romain Banchereau, Avantika S. Chitre, Alexis Scherl, Thomas D. Wu, Namrata S. Patil, Patricia de Almeida, Edward E. Kadel, III, Shravan Madireddi, Amelia Au-Yeung, Chikara Takahashi, Ying-Jiun Chen, Rhea Nersesian, Ehab A. El-Gabry, Mark D. Robida, Jeffrey C. Hung, Shadi Toghi Eshgi, W. Rodney Mathews, William E O'Gorman

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 4 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/9/4/e002231.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/ccc1e210948b41af9f921790f0cfde0d

المؤلفون: Yan Qu, Ira Mellman, Ellen Duong, Thomas D Wu, Eugene Y Chiang, Katherine Nutsch, Karl L Banta, Charles W Tran, Stephanie Mittman, Barzin Y Nabet, Namrata S Patil

المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/5a68ddaf764c4d40afd06e0a458c6d04

المؤلفون: Zoe June F. Assaf, Wei Zou, Alexander D. Fine, Mark A. Socinski, Amanda Young, Doron Lipson, Jonathan F. Freidin, Mark Kennedy, Eliana Polisecki, Makoto Nishio, David Fabrizio, Geoffrey R. Oxnard, Craig Cummings, Anja Rode, Martin Reck, Namrata S. Patil, Mark Lee, David S. Shames, Katja Schulze

المصدر: Nature Medicine. 29:859-868

مصطلحات موضوعية: General Medicine, General Biochemistry, Genetics and Molecular Biology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cf1722c81b0f7dd576630a9d0aa4e8b7
https://doi.org/10.1038/s41591-023-02226-6

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/journal_contribution/S1_List_-/13706907

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.s005

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/journal_contribution/CRP_decrease_is_associated_with_OS_post-atezolizumab_treatment_even_in_patients_with_high_CRP_levels_at_baseline_/13706895

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.s001

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/journal_contribution/Patient_demographics_in_the_two_treatment_arms_in_OAK_/13706901

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.s003

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/journal_contribution/Patient_clinical_characteristics_in_the_two_treatment_arms_in_OAK_/13706904

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.s004

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/journal_contribution/Names_and_addresses_of_institutional_review_boards_ethics_committees_/13706910

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.s006

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/journal_contribution/Receiver_operating_characteristic_ROC_plots_show_the_ability_of_CRP_decrease_FC_1_5_to_predict_1-year_OS_/13706898

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.s002

المؤلفون: Namrata S Patil, Wei Zou, Simonetta Mocci, Alan Sandler, Marcus Ballinger, Susan Flynn, Marcin Kowanetz, Priti S Hegde

المصدر: PLoS ONE, Vol 16, Iss 2, p e0246486 (2021)

مصطلحات موضوعية: Medicine, Science

Relation: https://doi.org/10.1371/journal.pone.0246486; https://doaj.org/toc/1932-6203; https://doaj.org/article/3cd9ebe18a8747349ef4cac75da859ee

الاتاحة: https://doi.org/10.1371/journal.pone.0246486
https://doaj.org/article/3cd9ebe18a8747349ef4cac75da859ee

المؤلفون: Aditi Qamra, Minu K. Srivastava, Eloisa Fuentes, Ben Trotter, Raymond Biju, Guillaume Chhor, James Cowan, Steven Gendreau, Webster Lincoln, Lisa McGinnis, Luciana Molinero, Namrata S. Patil, Amber Schedlbauer, Katja Schulze, Adam Stanford-Moore, Laura Chambre, Ilan Wapinski, David S. Shames, Hartmut Koeppen, Stephanie Hennek, Jane Fridlyand, Jennifer M. Giltnane, Assaf Amitai

المصدر: Cancer Research. 83:5705-5705

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2d45ecb7ab2185e0ca32a7a503e3be01
https://doi.org/10.1158/1538-7445.am2023-5705

المؤلفون: Namrata S. Patil, Shyam Srivats, Yoonha Choi, Xiangnan Guan, Barzin Nabet, Lisa McGinnis, Eugene Chiang, Alexis Dunkle, Bill O’Gorman, Patrick S. Chang, Ruozhen Hu, John Silva, Joy Han, Amelia Au-Yeung, Chikara Takahashi, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil-Bazo, Enriqueta Felip, Ira Mellman, Raymond Meng, Sanjeev Mariathasan, Robert Johnston, David S. Shames

المصدر: Cancer Research. 83:5712-5712

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::24753044e2fa90ac2e90572444b63dbf
https://doi.org/10.1158/1538-7445.am2023-5712

المؤلفون: Darya Orlova, Xiao Li, Jefferey Eastham-Anderson, Wei Zou, Evgeniy Tabatsky, Jennifer M. Giltnane, Namrata S. Patil, Maureen Peterson, Andries Zijlstra, Hartmut Koeppen

المصدر: Journal of Clinical Oncology. 40:2626-2626

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::266c3eca23566bf409fb1ac32fe3b11f
https://doi.org/10.1200/jco.2022.40.16_suppl.2626

المؤلفون: Namrata S. Patil, Barzin Y. Nabet, Sören Müller, Hartmut Koeppen, Wei Zou, Jennifer Giltnane, Amelia Au-Yeung, Shyam Srivats, Jason H. Cheng, Chikara Takahashi, Patricia E. de Almeida, Avantika S. Chitre, Jane L. Grogan, Linda Rangell, Sangeeta Jayakar, Maureen Peterson, Allison W. Hsia, William E. O’Gorman, Marcus Ballinger, Romain Banchereau, David S. Shames

المصدر: Cancer Cell. 40:289-300.e4

مصطلحات موضوعية: Cancer Research, Lung Neoplasms, Oncology, Carcinoma, Non-Small-Cell Lung, Plasma Cells, Humans, Immune Checkpoint Inhibitors, B7-H1 Antigen

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1819ce15d429daff54cb2e2e0cccbb6e
https://doi.org/10.1016/j.ccell.2022.02.002

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/figure/CRP_ratios_relative_to_pre-treatment_is_associated_with_overall_response_post-atezolizumab_treatment_but_not_with_docetaxel_treatment_in_the_POPLAR_and_OAK_studies_/13706916

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.g002

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/figure/Modulation_of_CRP_relative_to_pre-treatment_is_associated_with_overall_response_post_atezolizumab_treatment_but_not_with_docetaxel_treatment_in_the_POPLAR_and_OAK_studies_/13706913

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.g001

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/figure/Landmark_OS_and_PFS_Kaplan-Meier_curves_for_patients_binned_by_CRP_changes_at_6_weeks_/13706919

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.g003

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/dataset/Patient_demographics_and_clinical_characteristics_in_the_three_CRP_fold_change_buckets_for_atezolizumab_in_OAK_/13706925

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.t002

المؤلفون: Namrata S. Patil (10090476), Wei Zou (107458), Simonetta Mocci (153156), Alan Sandler (3474500), Marcus Ballinger (7374869), Susan Flynn (7374866), Marcin Kowanetz (93924), Priti S. Hegde (5349659)

مصطلحات موضوعية: Biochemistry, Medicine, Microbiology, Cell Biology, Molecular Biology, Biotechnology, Immunology, Cancer, Infectious Diseases, Virology, CPI, Phase III OAK study, non-small cell lung cancer, randomized Phase II, survival, serum CRP levels, Phase II POPLAR study, OS, RECIST, non-small cell lung cancer patients., PD, CRP levels post-treatment, C-reactive protein reduction post t., NSCLC, serum C-reactive protein, 6 weeks post-initiation, SD, weeks post treatment, serum CRP correlates, CRP levels

Relation: https://figshare.com/articles/dataset/Patient_demographics_and_clinical_characteristics_in_the_three_CRP_fold_change_buckets_for_docetaxel_in_OAK_/13706928

الاتاحة: https://doi.org/10.1371/journal.pone.0246486.t003